Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Janux Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 216
- +57 vs. Q3 2024
- Shares held
- 64.1M
- +18.7M (+41.2%) vs. Q3 2024
- Total value
- $3.43B
- +$1.37B (+66.3%) vs. Q3 2024
- New holders
- 78
- 80 more added
- Sold out
- 21
- 43 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Holocene Advisors, LP | 1,015,060 | $54.3M | 0.18% | +1,015,060 | New |
| Price T Rowe Associates Inc | 1,109,978 | $59.4M | 0.01% | +950,557+596.3% | Added |
| Logos Global Management LP | 1,250,000 | $66.9M | 7.83% | +250,000+25.0% | Added |
| Lord, Abbett & Co. LLC | 1,267,803 | $67.9M | 0.21% | +564,322+80.2% | Added |
| State Street Corp | 1,267,949 | $67.9M | 0.00% | −93,229−6.8% | Reduced |
| Citadel Advisors LLC | 1,360,878 | $72.9M | 0.07% | +351,110+34.8% | Added |
| EcoR1 Capital, LLC | 1,469,818 | $78.7M | 3.15% | 00.0% | Unchanged |
| Woodline Partners LP | 1,852,187 | $99.2M | 0.67% | +251,924+15.7% | Added |
| Cormorant Asset Management, LP | 2,100,000 | $112.4M | 6.17% | +1,050,000+100.0% | Added |
| Vanguard Group Inc | 2,136,332 | $114.4M | 0.00% | +288,402+15.6% | Added |
| BlackRock, Inc. | 2,725,813 | $145.9M | 0.00% | +303,177+12.5% | Added |
| Adage Capital Partners GP, L.L.C. | 3,061,750 | $163.9M | 0.29% | +986,750+47.6% | Added |
| Paradigm Biocapital Advisors LP | 3,515,986 | $188.2M | 6.55% | +1,115,412+46.5% | Added |
| Janus Henderson Group PLC | 3,562,402 | $190.6M | 0.10% | +1,038,996+41.2% | Added |
| FMR LLC | 8,669,941 | $464.2M | 0.03% | +845,266+10.8% | Added |
| Ra Capital Management, L.P. | 10,365,652 | $555.0M | 7.39% | +1,200,000+13.1% | Added |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −485,000−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −137,105−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −83,989−100.0% | Sold out |
| Blue Owl Capital Holdings LP | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −63,215−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −31,010−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −20,674−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −14,888−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Ovata Capital Management Ltd | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −9,300−100.0% | Sold out |
| Valence8 US LP | 0 | $0 | 0.00% | −7,857−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −6,971−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −6,413−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −5,738−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −5,400−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −5,140−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −4,599−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |